Skip to content
2000
image of An Assessment of BHLHE40 Transcription Factor Level and its Target Cytokines in Patients with Rheumatoid Arthritis

Abstract

Basic helix-loop-helix protein 40 (BHLHE40) can function as both a transcriptional activator and repressor. Recent studies have reported its regulatory functions in T helper (Th)1 and Th17 immune responses. Rheumatoid arthritis (RA) is an autoimmune inflammatory disease in which joints are involved. Both Th1 and Th17 contribute to the pathogenesis of the disease. In the present study, the levels of BHLHE40, interleukin 17 (), and interferon-gamma () were assessed in the RA patients.

Two groups, including RA patients and healthy individuals, were included in the study. The relative expression levels of BHLHE40, , and were quantified in peripheral blood mononuclear cells (PBMCs) using real-time PCR.

The results showed that the level of was significantly higher in RA patients compared to the healthy control ( < 0.001) (11.1-fold increase). Accordingly, a significant increase in the levels of (8.1 folds increase) ( < 0.021) and (12.7 folds) ( < 0.001) was observed.

Evaluation of the expression level of in RA patients showed a significant increase. In line with the elevated level of BHLHE40, a significant increase in the expression level of and was also detected. These findings point to the possible role of BHLHE40 in the disease course or severity by elevating the levels of inflammatory cytokines, including and . Therefore, BHLHE40 might be considered either as a putative biomarker or as a candidate for therapy in a variety of human diseases.

Loading

Article metrics loading...

/content/journals/raiad/10.2174/0127722708331558250129152044
2025-02-04
2025-06-20
Loading full text...

Full text loading...

References

  1. Geusens P. The role of RANK ligand/osteoprotegerin in rheumatoid arthritis. Ther. Adv. Musculoskelet. Dis. 2012 4 4 225 233 10.1177/1759720X12438080 22859921
    [Google Scholar]
  2. Benjamin O. Goyal A. Lappin S.L. Disease Modifying Anti-Rheumatic Drugs (DMARD). StatPearls Treasure Island (FL): StatPearls Publishing 2022
    [Google Scholar]
  3. Chang H.C. Kao C.H. Chung S.Y. Chen W.C. Aninda L.P. Chen Y.H. Juan Y.A. Chen S.L. Bhlhe40 differentially regulates the function and number of peroxisomes and mitochondria in myogenic cells. Redox Biol. 2019 20 321 333 10.1016/j.redox.2018.10.009 30391825
    [Google Scholar]
  4. Lin C.C. Bradstreet T.R. Schwarzkopf E.A. Sim J. Carrero J.A. Chou C. Cook L.E. Egawa T. Taneja R. Murphy T.L. Russell J.H. Edelson B.T. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Nat. Commun. 2014 5 1 3551 10.1038/ncomms4551 24699451
    [Google Scholar]
  5. Kanda M. Yamanaka H. Kojo S. Usui Y. Honda H. Sotomaru Y. Harada M. Taniguchi M. Suzuki N. Atsumi T. Wada H. Baghdadi M. Seino K. Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in i NKT cells. Proc. Natl. Acad. Sci. USA 2016 113 24 E3394 E3402 10.1073/pnas.1604178113 27226296
    [Google Scholar]
  6. Miyazaki K. Miyazaki M. Guo Y. Yamasaki N. Kanno M. Honda Z. Oda H. Kawamoto H. Honda H. The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells. J. Immunol. 2010 185 12 7330 7339 10.4049/jimmunol.1001381 21057086
    [Google Scholar]
  7. Arnett F.C. Edworthy S.M. Bloch D.A. Mcshane D.J. Fries J.F. Cooper N.S. Healey L.A. Kaplan S.R. Liang M.H. Luthra H.S. Medsger T.A. Jr Mitchell D.M. Neustadt D.H. Pinals R.S. Schaller J.G. Sharp J.T. Wilder R.L. Hunder G.G. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 31 3 315 324 10.1002/art.1780310302 3358796
    [Google Scholar]
  8. Matsui T. Kuga Y. Kaneko A. Nishino J. Eto Y. Chiba N. Yasuda M. Saisho K. Shimada K. Tohma S. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann. Rheum. Dis. 2007 66 9 1221 1226 10.1136/ard.2006.063834 17369281
    [Google Scholar]
  9. Livak K.J. Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 4 402 408 10.1006/meth.2001.1262 11846609
    [Google Scholar]
  10. Cook M.E. Jarjour N.N. Lin C.C. Edelson B.T. Transcription Factor Bhlhe40 in Immunity and Autoimmunity. Trends Immunol. 2020 41 11 1023 1036 10.1016/j.it.2020.09.002 33039338
    [Google Scholar]
  11. El-Behi M. Ciric B. Dai H. Yan Y. Cullimore M. Safavi F. Zhang G.X. Dittel B.N. Rostami A. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011 12 6 568 575 10.1038/ni.2031 21516111
    [Google Scholar]
  12. McGeachy M.J. GM-CSF: The secret weapon in the TH17 arsenal. Nat. Immunol. 2011 12 6 521 522 10.1038/ni.2044 21587311
    [Google Scholar]
  13. Lin C.C. Bradstreet T.R. Schwarzkopf E.A. Jarjour N.N. Chou C. Archambault A.S. Sim J. Zinselmeyer B.H. Carrero J.A. Wu G.F. Taneja R. Artyomov M.N. Russell J.H. Edelson B.T. IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J. Exp. Med. 2016 213 2 251 271 10.1084/jem.20150568 26834156
    [Google Scholar]
  14. Martínez-Llordella M. Esensten J.H. Bailey-Bucktrout S.L. Lipsky R.H. Marini A. Chen J. Mughal M. Mattson M.P. Taub D.D. Bluestone J.A. CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response. J. Exp. Med. 2013 210 8 1603 1619 10.1084/jem.20122387 23878307
    [Google Scholar]
  15. Bettelli E. Nicholson L.B. Kuchroo V.K. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J. Autoimmun. 2003 20 4 265 267 10.1016/S0896‑8411(03)00048‑9 12791309
    [Google Scholar]
  16. Codarri L. Gyülvészi G. Tosevski V. Hesske L. Fontana A. Magnenat L. Suter T. Becher B. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011 12 6 560 567 10.1038/ni.2027 21516112
    [Google Scholar]
  17. Pascal L.E. True L.D. Campbell D.S. Deutsch E.W. Risk M. Coleman I.M. Eichner L.J. Nelson P.S. Liu A.Y. Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 2008 9 1 246 10.1186/1471‑2164‑9‑246 18501003
    [Google Scholar]
  18. Tsuyama T. Sato Y. Yoshizawa T. Matsuoka T. Yamagata K. Hypoxia causes pancreatic β-cell dysfunction by activating a transcriptional repressor BHLHE40. bioRxiv 2022 2022 498031 10.1101/2022.06.28.498031
    [Google Scholar]
  19. Rauschmeier R. Gustafsson C. Reinhardt A. A-Gonzalez N. Tortola L. Cansever D. Subramanian S. Taneja R. Rossner M.J. Sieweke M.H. Greter M. Månsson R. Busslinger M. Kreslavsky T. Bhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self‐renewal and identity. EMBO J. 2019 38 19 e101233 10.15252/embj.2018101233 31414712
    [Google Scholar]
/content/journals/raiad/10.2174/0127722708331558250129152044
Loading
/content/journals/raiad/10.2174/0127722708331558250129152044
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: BHLHE40 ; IL-17 ; rheumatoid arthritis ; IFN-γ
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test